Hans Jeppsson
Director of Finance/CFO at VICORE PHARMA HOLDING AB
Net worth: 6 865 $ as of 2024-03-30
Profile
Hans Jeppsson is currently the Deputy Director at Vicore Pharma AB and INIM Pharma AB.
He is also the Chief Financial Officer at Vicore Pharma Holding AB since 2017.
Previously, he worked as a Research Analyst at Danske Bank A.
Dr. Jeppsson has a graduate and doctorate degree from the University of Gothenburg and Handelshögskolan i Göteborg.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VICORE PHARMA HOLDING AB
0.00% | 2023-09-28 | 5,000 ( 0.00% ) | 6 865 $ | 2024-03-30 |
Hans Jeppsson active positions
Companies | Position | Start |
---|---|---|
VICORE PHARMA HOLDING AB | Director of Finance/CFO | 2016-12-31 |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Former positions of Hans Jeppsson
Companies | Position | End |
---|---|---|
Danske Bank A/S (Sweden) | Analyst-Equity | - |
Training of Hans Jeppsson
University of Gothenburg | Doctorate Degree |
Handelshögskolan i Göteborg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VICORE PHARMA HOLDING AB | Health Technology |
Private companies | 3 |
---|---|
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
Danske Bank A/S (Sweden) | Finance |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Hans Jeppsson